SB1317 (TG-02)

CAT: 0026-B3218-5Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0026-B3218-5Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

SB1317 is a potent inhibitor of CDK2, JAK2, and FLT3 with IC50 of 13, 73, and 56 nM, respectively. SB1317 may be useful for the treatment of cancer that crosses the blood brain barrier and acts by depleting Myc through the inhibition of cyclin-dependent kinase 9 (CDK9).

Shipping Conditions

Gel Pack

Storage Conditions

-20ºC

Shelf Life

36 months

Related Products

Catalog	Name
B3220-5	TG-101209
B3220-25	TG-101209
B1215-25	TA-02
B1215-5	TA-02
K614-100	PicoProbe™ Triglyceride (TG) Fluorometric Assay Kit
2450-5	SB1518 (Pacritinib)
2450-1	SB1518 (Pacritinib)

Alternative Products

Catalog	Name
MBS386287-01	TG-02 (SB1317)
MBS5750089	SB1317 (TG-02) hydrochloride
A11962-100	(E/Z) -Zotiraciclib ((E/Z) -TG-02, (E/Z) -SB1317) 100mg
A11962-2	(E/Z) -Zotiraciclib ((E/Z) -TG-02, (E/Z) -SB1317) 2mg
A11962-50	(E/Z) -Zotiraciclib ((E/Z) -TG-02, (E/Z) -SB1317) 50mg
A11962-1	(E/Z) -Zotiraciclib ((E/Z) -TG-02, (E/Z) -SB1317) 1mg
A11962-10mM-D	(E/Z) -Zotiraciclib ((E/Z) -TG-02, (E/Z) -SB1317) 10mM * 1mL in DMSO
AR-T01765-01	TG-02
467441-01	TG 02
T2653-01	SB1317

SB1317 (TG-02)

Related Products

Alternative Products

Popular Products